Vitiligo
RecruitingStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
- Disease:Vitiligo
- Substances:Ruxolitinib
Spain- Participants:0–17 years
- Substances:Ruxolitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to Spain546 clinical trials in Zaragoza, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on advanced cancer treatments and blood disorders, including studies of new therapies for lung cancer, pancreatic adenocarcinoma, and various hematologic malignancies.
Multiple trials evaluating combination therapies and novel treatment approaches for both solid tumors and blood cancers.
Research into treatments for various inflammatory and autoimmune disorders, with emphasis on chronic conditions affecting quality of life.
Studies focusing on innovative biological therapies and targeted treatments for inflammatory conditions.
Studies addressing critical cardiovascular health challenges and metabolic conditions, including innovative approaches to stroke treatment and lipid management.
Focus on developing new therapeutic options for both acute and chronic cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.